Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
This study has been withdrawn prior to enrollment.
Burzynski Research Institute
Information provided by:
National Cancer Institute (NCI)
First received: November 1, 1999
Last updated: July 9, 2013
Last verified: December 2006
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||No date given|
|Primary Completion Date:||No date given|